Signum Biosciences

0 followers


Signum Biosciences develops small molecule therapeutics derived from its STM platform to modulate signal transduction imbalances.

Employees

11-50

Links

Org chart

Maxwell Stock
CEO & Founder

Maxwell Stock

Collapse
Lisa Johnson
Senior Vice President Of Global Sales & Corporate Development
Masanori (Markie) Tamura
Vice President of Product Development
Michael J. Losch
Chief Financial Officer
Jose Fernandez
Director of Research & Development
José R. Fernández
Director of Research and Development